RxDoctor Payments DataLook up a doctor →

Alyglo: payments to doctors

Payments that named Alyglo as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$72K
Providers
461
Transactions
880
Average per transaction
$82

The per-transaction average — $82 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 461 providers the average total is $157, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
GC Biopharma USA, Inc.$72,15499.8%
GC Biopharma Corp.$1110.2%
← All drugs & devices